Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity. (2022)
Attributed to:
MRC Centre for Neurodevelopmental Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12974-022-02625-5
PubMed Identifier: 36309753
Publication URI: http://europepmc.org/abstract/MED/36309753
Type: Journal Article/Review
Volume: 19
Parent Publication: Journal of neuroinflammation
Issue: 1
ISSN: 1742-2094